Atrys Health Sa · BME:ATRY
Atrys Health Sa — 9M 2025 Earnings Presentation
15 slides from Atrys Health Sa's earnings presentation, Nov 14, 2025
Slide 1: Financial Results Presentation 3Q 2025
14th November 2025 Financial Results Presentation 3Q 2025
Slide 2: Disclaimer and Cautionary Statements
Disclaimer and Cautionary Statements This document and the results conference (including the Q&A session) may contain Except as required by applicable law, ATRYS assumes no obligation to publicly update forward-looking statements and information (hereinafter, “Statements”) relating to the outcome of
Slide 3: Highlights 9M25
Highlights 9M25 Key Financials 9M25 Summary €168.4M +8.2% Revenue During the first nine months of 2025, Atrys continued to deliver solid and sustained organic growth, recording an 8.2% year-to-date increase. Growth €105.2M +2.5% Gross Margin (APM) accelerated to +9.2% in Q3 2025, compared with 7.8%
Slide 4: Key financials 9M25
Key financials 9M25 Revenues Gross Margin (APM) Adj. EBITDA (APM) CAPEX(APM) Adj. Operating Cash flow(APM) 168.4 +8.2% 155.6 +2.5% 102.6 105.2 (10.5)% 31.1 27.9 23.2 (20.2)% +17.7 18.5 (7.9) % (9.3) 9M24 9M25 9M24 9M25 9M24 9M25 9M24 9M25 9M24 9M25 Revenue grew by 8.2% compared The Gross Margin over
Slide 5: Key financial 9M25 by business segment
Key financial 9M25 by business segment ONCOLOGY DIAGNOSTICS PREVENTIVE MEDICINE Revenues / EBITDA (APM) Revenues / EBITDA (APM) Revenues / EBITDA (APM) +0.3% +5.9% +21.2% +13.9% +2.9% +9.3% 9M24 9M25 9M24 9M25 9M24 9M25 EBITDA Revenue EBITDA Revenues EBITDA Revenues Unaudited Figures in thousands EU
Slide 6: Key financial 9M25 by business segment
Key financial 9M25 by business segment % Revenue by Business Segment % EBITDA (APM) by Business Segment 32.8% 26.5% 36.6% 37.2% 36.3% 30.6% Oncology Diagnostics Prevention Oncology Diagnostics Prevention Unaudited Figures in thousands EUR. 6 (APM) See Alternative Performance Measures definitions in
Slide 7: Revenues by Geography 9M25
Revenues by Geograpghy 9M25 Portugal Colombia +8.9% +15.2% 12.1M€ 4.0M€ 7.2% Brazil 12.3% +2.9% LatAm Chile 4.4M€ 13.6% Spain 73.6% 19.3% +6.6% (5.4)% 54.9% +8.4% 32.4M€ 17.8M€ 123.9M€ 19.1% Mexico (1.8)% At constant FX +63.5% 6.2M€ Unaudited Figures in millions EUR. 7
Slide 8: Oncology
Oncology Medical Oncology Spain: Revenue reached €35.6 million in the first nine months of 2025, representing +21.6% growth vs. 9M24, driven by strong LTM Revenue and Gross Margin (%) Trend demand for capitation management services from the insurance sector. Gross Margin over Revenue is showing prog
Slide 9: Diagnostics
Diagnostics Telemedicine: Revenue reached €32.8 million in the first nine months of LTM Revenue and Gross Margin (%) Trend 2025, representing +1.7% growth vs. 9M24, despite a 5.4% decline in revenue from Chile. This decrease reflects the strategic decision to discontinue business lines that contribu
Slide 10: Rationale for the divestment of the Prevention segment
Rationale for the divestment of the Prevention segment Focus on businesses with higher growth potential and financial discipline The Enterprise Value of the transaction amounts to €145 million, subject to: i) approval by Atrys’ General Shareholders’ Meeting, ii) authorisation from the lenders of Atr
Slide 11: Financial Information
ANNEX I Financial Information 11
Slide 12: Quarterly trends in key financial metrics
ANNEX I Quarterly trends in key financial metrics Cifras no auditadas en miles de euros. (MAR) Ver Anexo II definición Medidas Alternativas de Rendimiento. Cifras ejercicio 2023 pro forma excluyendo Conversia del perímetro del Grupo.
Slide 13: Alternative Performance Measures Definitions
ANNEX II Alternative Performance Measures Definitions 13
Slide 14: Alternative Performance Measures Definitions
ANNEX II Alternative Performance Measures Definitions Gross Profit: Net revenue minus cost of goods sold. Considered a performance CAPEX: Cash outflows related to the Group’s productive capacity and measure as it asset profitability (from shows net sales after deducting the costs incurred to achieve
Slide 15: atryshealth.com
atryshealth.com at rys